Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Active, Not Recruiting
Checked: June 1, 2026 at 10:07 PM UTC
| NCT Number | NCT05445778 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Ovarian Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 520 participants |
| Active Locations | 70 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | May 26, 2026 (6 days ago) |
As of June 1, 2026: Clinical trial NCT05445778 is currently active_not_recruiting participants. This clinical trial study for ovarian cancer is not currently accepting new participants at 70 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05445778 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 70 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05445778 was last updated 6 days ago (May 26, 2026). HelloStudys verifies this status automatically.